期刊文献+

疾病进程模型的研究进展 被引量:2

Advances in disease progress model
原文传递
导出
摘要 疾病进程模型是一种描述疾病状态随时间动态变化的模型。它作为基于模型的药物研发的新趋势,正迅速成为研究药物如何影响疾病的重要手段。通过对疾病进程模型的研究能对未来疾病的变化趋势作出预测,结合个体信息及时调整治疗方案。本文对近年来被成功应用的几种疾病进程模型及药物干预模式进行了总结,并探讨了对疾病进程建模及模拟的应用前景。 As a new trend in model-based drug development, disease progress model is a quantitative model that accounts for the time course of disease status. It is rapidly becoming an important method to study how the drug acting on the disease. To make the treatment appropriate to a specific patient, the changing trend of the individual disease can be predicted by the study of disease progress model. We summarized some of disease progress models and drug action mode which have been successfully used in recent years, and discussed the prospect of modeling and simulation of disease progression model.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2012年第8期425-431,共7页 Chinese Journal of New Drugs and Clinical Remedies
基金 上海市教委创新项目(10YZ61) 上海市教委E研究院建设计划项目(E03008) 高等学校博士学科点专项科研基金项目(20103107120014)
关键词 定量药理学 药理学 临床 疾病进程模型 临床试验 pharmacometrics pharmacology, clinical disease progress model clinical trails
  • 相关文献

参考文献25

  • 1KIMKO HC, REELE SS, HOLFORD NH, et ol. Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model[J]. Clin Pharmacol Ther, 2000, 68(5): 568-577.
  • 2MOULD DR. Developing models of disease progression[M]/ZENE IE, PAUL JW. Pharmacometrics: the science of quantitative pharmacology. Hoboken: John Wiley & Sons. Inc. 2007: 547- 576.
  • 3HOLFORD NH, PEACE KE. Methodologic aspects of a population pharmacodynamic modelA|zheimer patients treated with tacrine[J]. Proc Natl Acad Sci U S A, 1992, 89(23): 11466-11470.
  • 4ITO K, AHADIEH S, CORRIGAN B, et ol. Disease progression meta-analysis model in Alzheimer's disease[J]. Alzheimers Dement, 2010, 6(1): 39-53.
  • 5HOLFORD NH, CHAN PL, NUTT JG, et aL Disease progression and pharmacodynamies in Parkinson disease- evidence for functional proteetion with levodopa and other treatments[J]. J Pharmacokinet Pharmacodyn, 2006, 33 (3): 281-311.
  • 6PORS NIELSEN S, BARENHOLDT O, HERMANSEN F, et al. Magnitude and pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment [J]. Br J Obstet Gynaeeol, 1994, 101(4) : 319-324.
  • 7ANDERSON B J, HOLFORD NH, WOOLLARD GA, et aL Perioperative pharmacodynamics of acetanlinophen analgesia in children[J]. Anesthesiology, 1999, 90(2) : 411-421.
  • 8HOLFORD N, LI J, BENINCOSA L, et al. Population disease progress models for the time course of HAMD score in depressed patients receiving placebo in antidepressant clinical trials [EB/ OL]. (2002) [2011 -04 -13]. http://www.page-meeting.org/? abstract=311.
  • 9HOLFORD N. The time coume of placebo response in clinical tri-s-lo antidepressants really take two weeks to work? [EB/OL]. (2005) [2011-04 - 13]. http ://holford.fmhs.auckland.ac.nz/ docs/AAPS Placebo & Anti-depressant_Response. ppt. pdf.
  • 10JACQMIN P. Modeling drug induced changes in biomarkers without using drug concentrations: introducing the K-PD model [EB/OL]. (2001) [2011-04-13]. http://www, page-meeting. org/? abstract=232.

同被引文献31

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部